Immunosuppressive agents for myasthenia gravis

Abstract Background The benefits of different immunosuppressants for myasthenia gravis (MG) are unclear. Objectives Assessment of immunosuppressant drug efficacy in MG. Search methods We searched the Cochrane Neuromuscular Disease Group Trials Register, MEDLINE (from January 1966 to July 2007), EMBASE (from January 1980 to July 2007), review and trial bibliographies and contacted trial authors. Selection […]